In plain language
This review describes robotic percutaneous coronary intervention (PCI) as feasible, with high technical success and reduced radiation exposure for the operator working in a shielded cockpit. Benefits for orthopedic injury are presumed rather than shown, and complex cases often need manual conversion.
At a glance
- Type of study
- Narrative review
- Who was studied
- Interventional cardiologists
- Summary based on
- the abstract
What it found
Robotic PCI lets the operator work from a radiation-shielded cockpit, with reduced operator radiation exposure listed as an advantage.
Advantages include accurate stent placement, reduced operator radiation exposure and a presumed (not demonstrated) reduction in orthopedic injuries.
Recent trials show high technical success and low complication rates.
Many complex cases still need at least partial conversion to manual PCI.
Technical limits include incompatibility with some intravascular imaging catheters and no simultaneous handling of multiple guidewires and stents. STEMI patients have largely been excluded from studies.
Limits to keep in mind
Narrative review summarised from the abstract only, with no quantitative data. The orthopedic benefit is presumed, and the evidence excludes complex and STEMI cases.
Related research summaries
- Radiation exposure in interventional cardiology: a narrative review of health effects and novel approaches to ensure radiation safety (2025, Narrative review)
- Narrative review of latest research progress about robotic percutaneous coronary intervention (2024, Narrative review)
- Radiation Exposure, Training, and Safety in Cardiology (2024, Narrative review)
- Robotic-Assisted Percutaneous Coronary Intervention: Concept, Data, and Clinical Application (2019, Narrative review)
- ACC - Radiation Safety for the Interventional Cardiologist (2015, Narrative review)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 5, 2026.